Leveraging informatics, mobile health technologies and biobanks to treat each patient right

Personalized Medicine
Bradford R Hirsch, Amy P Abernethy

Abstract

Personalized medicine is the future of clinical care. Many interpret this to mean that advances in genomic medicine will revolutionize care. However, the reality is much more complex, relying on a combination of health technology, patient engagement, genomics, basic sciences and decision-support tools to move the field forward. There are a number of instances in which providers and researchers have already made significant progress toward the goal, yet the advances often occur in isolation and are not widely acknowledged. With appropriate investment, coordination and vision, the present state can be leveraged to change our approach to a given patient within the next few years. Here we demonstrate how currently available informatics, mobile health technology and biobanking solutions can support personalization of care in the near term, and lead to the development of a learning health system.

References

May 9, 2000·American Journal of Public Health·J N Izquierdo, V J Schoenbach
Jul 13, 2004·International Journal of Medical Informatics·Lucila Ohno-MachadoStaal Vinterbo
Jul 18, 2006·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Scott D Grosse, Muin J Khoury
Jan 5, 2008·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·J M ValderasJ Alonso
Jul 4, 2008·The New England Journal of Medicine·Shyamala MaheswaranDaniel A Haber
Jan 29, 2009·Health Affairs·Caroline Lubick GoldzweigPaul G Shekelle
May 8, 2009·The New England Journal of Medicine·Jerry Avorn
May 19, 2009·BMC Medical Informatics and Decision Making·William Hersh
Jul 2, 2009·The New England Journal of Medicine·John K Iglehart
Nov 26, 2009·Translational Research : the Journal of Laboratory and Clinical Medicine·Geoffrey S Ginsburg, Huntington F Willard
Dec 3, 2009·Current Opinion in Supportive and Palliative Care·Amy P AbernethyS Yousuf Zafar
Jan 28, 2010·JAMA : the Journal of the American Medical Association·Ralph Snyderman, Michaela A Dinan
Apr 3, 2010·Nature·Francis Collins
Jun 17, 2010·The New England Journal of Medicine·Margaret A Hamburg, Francis S Collins
Jun 25, 2010·The New England Journal of Medicine·Makoto MaemondoUNKNOWN North-East Japan Study Group
Jun 30, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Zsofia K StadlerKenneth Offit
Jul 22, 2010·The New England Journal of Medicine·David Blumenthal, Marilyn Tavenner
Sep 14, 2010·PharmacoEconomics·Robert S Epstein, J Russell Teagarden
Oct 21, 2010·JAMA : the Journal of the American Medical Association·Ashish K Jha
Dec 21, 2010·Journal of the American Medical Informatics Association : JAMIA·Bradley MalinDaniel Masys
Jan 14, 2011·The New England Journal of Medicine·Rachel E BehrmanRichard Platt
Jan 21, 2011·The New England Journal of Medicine·Jim McDermott
Jan 27, 2011·JAMA : the Journal of the American Medical Association·Paul Sullivan, Don Goldmann
Jan 28, 2011·The New England Journal of Medicine·Ultan McDermottMichael R Stratton
Aug 17, 2011·The Journal of Rheumatology·Stephan McBrideJoseph A Johnston
Sep 23, 2011·Science Translational Medicine·Geoffrey S GinsburgAmy P Abernethy
Jan 9, 2012·Journal of Biomedical Informatics·Daniel R MasysHoward P Levy
Jan 25, 2012·Pharmacoepidemiology and Drug Safety·Lesley H CurtisJeffrey S Brown
Jan 25, 2012·Pharmacoepidemiology and Drug Safety·Sarah L CutronaJerry H Gurwitz
Feb 7, 2012·Chronic Respiratory Disease·Arif H KamalAmy P Abernethy
Feb 16, 2012·The New England Journal of Medicine·Frederic S Resnic, Sharon-Lise T Normand
Mar 9, 2012·The New England Journal of Medicine·Marco GerlingerCharles Swanton
May 11, 2012·Pharmacoepidemiology and Drug Safety·Sebastian SchneeweissScott R Smith

❮ Previous
Next ❯

Citations

Nov 20, 2019·Informatics for Health & Social Care·Yiannis Koumpouros, Aggelos Georgoulas
Jun 1, 2015·Personalized Medicine·Patrick A GladdingTodd T Schlegel

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy

Software Mentioned

Apache Hadoop
Hadoop
Epi Surveyor
DataSphere

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Trustee : the Journal for Hospital Governing Boards
L Larson
International Journal of Dental Hygiene
Maria Perno Goldie
© 2022 Meta ULC. All rights reserved